Trump Administration Weighs Executive Order on Vaccines and Autism Research

The Trump administration is considering an executive order focused on vaccines and autism research that could be announced as early as next week, Bloomberg News reported Friday, citing people familiar with the discussions.

Administration officials are reportedly reviewing several possible measures, including new autism research initiatives involving both prospective studies and retrospective analyses. However, the proposal remains under consideration, meaning its scope, timing and final provisions could still change.

The potential executive order comes as President Donald Trump’s administration continues to reassess U.S. childhood vaccination policy. White House spokesman Kush Desai said Trump wants the United States to have “the best childhood vaccine schedule in the world” and remains committed to what the administration calls “Gold Standard Science” when addressing parents’ concerns about vaccines.

Extensive scientific research has found no causal connection between childhood vaccines and autism. Decades of studies have also shown that autism does not have a single identified cause, with researchers pointing to a complex combination of genetic and environmental factors.

The possible order would add to broader Trump administration efforts to review the country’s childhood vaccine recommendations. An executive order issued in May sought to bring the U.S. vaccination schedule more closely in line with countries that recommend fewer childhood immunizations.

At the same time, Health and Human Services Secretary Robert F. Kennedy Jr. has faced legal setbacks in attempts to modify vaccine recommendations and restructure the advisory committee responsible for providing guidance on immunization policy.

Bloomberg reported that autism and vaccine policy had previously been regarded as politically sensitive ahead of the U.S. midterm elections. An internal memo earlier this year reportedly encouraged federal health officials to emphasize less divisive subjects in public communications, including food guidelines and healthcare costs.

Interest in the administration’s autism research efforts increased again last week when Trump publicly questioned Kennedy about progress during a Cabinet meeting. Kennedy responded that officials expected to provide an answer.

Any executive order on vaccines and autism could renew public and political debate over U.S. vaccination policy while putting additional attention on the administration’s approach to autism research and federal health policy.